IP Library › Granted Patent US 10,472,383
Granted Patent B2
US 10,472,383 · App. 15/460,475 · Granted Nov 12, 2019

Nucleoside triphosphates with stable aminoxy groups

Inventor: Steven A Benner (Gainesville, FL)
C07H19/10C07H19/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,472,383
App. No.
15/460,475
Granted
Nov 12, 2019
Kind
B2
Abstract

This invention claims aqueous compositions that comprise triphosphates of 2′-deoxynucleoside derivatives that have, instead of a 3′-OH moiety, a 3′-ONH 2 moiety; wherein said compositions contain less than 0.5 mole percent contaminating triphosphate having a 3′-OH moiety, as well as processes for providing such compositions. The compositions further must contain insubstantial amounts of hydroxylamine.

Claims (26)

1. A composition comprising an aqueous solution containing an alkoxylamine, hydroxylamine at a concentration of less than 1 micromolar and a molecule having the structure:

or one of its ionized forms, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is either H, CH 3 , or a functionalized side chain, and X is either N or C—R.

2. The composition of claim 1 , wherein said alkoxylamine is methoxylamine.

3. The composition of claim 1 , wherein said heterocycle B is selected from the group consisting of thymine, uracil, cytosine, guanine, adenine, 7-deazaadenine, 7-deazaguanine, and isocytosine and the alkoxylamine is methoxylamine.

4. The composition of claim 1 , wherein said heterocycle B is selected from the group consisting of thymine and isocytosine and the alkoxylamine is methoxylamine.

5. The composition of claim 1 , wherein appended to heterocycle B is a linker that comprises either a disulfide moiety or a 1,2-diol moiety and the alkoxylamine is methoxylamine.

6. A process for preparing a compound of having the structure:

or one of its ionized forms, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is H, CH 3 , or a functionalized side chain, and X is either N or C—R, wherein said process comprises:

(a) contacting a solid phase having an immobilized aldehyde or ketone moiety with compound having the following structure

wherein Q is either H or a dimethoxytrityl group, and B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is H, CH 3 , or a functionalized side chain, and X is either N or C—R, followed by

(b) contacting the composition from step (a) with 2-chloro-4H-1,3,2-benzodioxaphosphorin-4-one, followed by

(c) contacting the composition from step (b) with an ammonium salt of a pyrophosphate, followed by

(d) oxidizing the composition from step (c), followed by

(e) washing the composition from step (d) with an aqueous solution comprising an alkoxylamine.

7. The process of claim 6 , wherein appended to heterocycle B is a linker that comprises either a disulfide moiety or a 1,2-diol moiety.

8. The process of claim 6 , wherein said heterocycle B is selected from the group consisting of thymine, uracil, cytosine, guanine, adenine, 7-deazaadenine, 7-deazaguanine, and isocytosine.

9. The process of claim 6 , wherein said heterocycle B is selected from the group consisting of thymine and isocytosine.

10. The process of claim 6 , wherein the alkoxylamine is methoxylamine.

11. The composition of claim 1 , wherein said solution contains less than 1 nanomolar hydroxylamine.

12. The composition of claim 1 , wherein the composition contains less than 0.5 mole percent of the molecule having the structure with a 3′-OH group relative to the molecule having the structure with a 3′-O—NH 2 group.

13. The composition of claim 1 , wherein the composition contains less than 0.05 mole percent of the molecule having the structure with a 3′-OH group relative to the molecule having the structure with a 3′-O—NH 2 group.

14. The process of claim 6 , comprising in step e) washing the composition from step (d) with the aqueous solution comprising the alkoxylamine, wherein the aqueous solution does not contain hydroxylamine.

15. The process of claim 6 , wherein the process does not comprise using hydroxylamine in any step after step d).

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 27, 2017
From: FOUNDATION FOR APPLIED MOLECULAR EVOLUTN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044309/0482 →
Continuity (1)
Related Publication 20180265537A1 · Sep 20, 2018
Cited By (2)
US 12,606,856 US 12,703,860